MedTrace Logo

Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications

NCT01374542 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2021-10-01

No results posted yet for this study

Summary

Background: Respiratory endoscopy comprises flexible bronchoscopy and medical thoracoscopy. The diagnostic yield, technical factors and complications for all patient sub-populations is still not clearly defined. This may result in inappropriate or even dangerous application of such procedures. The aim of the study is to collect data on these aspects of respiratory endoscopy and identify important trends, as well as, areas for improvement. This data will also provide baseline comparative data for new bronchoscopic techniques such as endobronchial ultrasound and navigational bronchoscopy.

Method: Prospective data collection. Technical details regarding these procedures are currently keyed into the OTM system by the endoscopy operators for documentation and billing. The department of Respiratory and Critical Care Medicine gets monthly downloads of all the fields from the OTM system for audit purposes.(See data collection form) The research project proposes to make the data non identifiable by removing the patient's name and IC number. Additionally the yield of the procedure will be checked by a chart review of the histology and microbiology results. There are no restrictions on patient recruitment because all procedures will be performed for clinical indications only and no patient will be recruited for the sole purpose of the study. Waiver of consent has been approved by the IRB.

Conditions

  • Lung Neoplasm
  • Lung Diseases, Interstitial
  • Respiratory Tract Infections
  • Pleural Effusions

Interventions

PROCEDURE

Respiratory endoscopy

Bronchoscopy, thoracoscopy, endobronchial ultrasound

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Principal Investigators

  • Devanand Anantham, MRCP · Singapore General Hospital

Eligibility

Min Age
10 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374542 on ClinicalTrials.gov